Clarification of methodology and further results from the pivotal phase 3 study of crisaborole for mild-moderate atopic dermatitis

A. S. Paller*

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)663-664
Number of pages2
JournalBritish Journal of Dermatology
Volume178
Issue number3
DOIs
StatePublished - Mar 2018

ASJC Scopus subject areas

  • Dermatology

Cite this